Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) (Q28209814)
scientific article (publication date: 15 December 2002)
Language:
(P31) (Q13442814)
(P50) (Q4793409)
(Q66385542)
(Q66429603)
(Q41899936)
(Q102213853)
(Q114529743)
(Q114529744)
(Q114529745)
(Q114341090)
(Q88557115)
(Q86566342)
(P304) 4325-36
(P407) (Q1860)
(P433) 13
(P478) 100
(P577) Sunday, December 15, 2002
(P921) (Q181600)
(Q29496)
(Q264118)
(P1433) (Q885070)
(P1476) "Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)" (language: en)
(P2093) Richard K Dodge
Andrew J Carroll
Shivanand R Patil
Michael S Watson
Joseph O Moore
Robert J Mayer
Eric J Feldman
Frederick R Davey
other details
description scientific article (publication date: 15 December 2002)

External Links